R&D Systems™ Recombinant Human FGFR4 Fc Chimera Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human FGF R4 Fc Chimera Protein is derived from NS0. The Recombinant Human FGF R4 Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 2264
• Molecular Weight (g/mol): 65 kDa (monomer)
• Name: FGFR4
• Quantity: 50 μg
• Source: Mouse myeloma cell line, NS0-derived human FGFR4 protein Human FGF R4 (Leu22-Asp369) (N-terminus) Accession # P22455 IEGRMD Human IgG1 (Pro100-Lys330) (L111C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Gene Alias: CD334, CD334 antigen, EC 2.7.10, EC 2.7.10.1, FGF R4, FGFR-4, fibroblast growth factor receptor 4, JTK2hydroxyaryl-protein kinase, MGC20292, protein-tyrosine kinase, TKF, tyrosine kinase related to fibroblast growth factor receptor, tyrosylprotein kinase
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.